Trials / Completed
CompletedNCT00144560
Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA)
An Open-Label, Clinical Pharmacology Study to Investigate Drug-Drug Interaction in Patients With RA
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Chugai Pharmaceutical · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is an open-label, clinical pharmacology study to investigate drug-drug interaction in patients with RA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MRA(Tocilizumab) |
Timeline
- Start date
- 2005-02-01
- Primary completion
- 2005-08-01
- Completion
- 2005-08-01
- First posted
- 2005-09-05
- Last updated
- 2008-12-15
Source: ClinicalTrials.gov record NCT00144560. Inclusion in this directory is not an endorsement.